We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Diagnostic Method Confirms Sepsis Infections Earlier

By LabMedica International staff writers
Posted on 01 Sep 2025

Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. More...

Each hour of delayed treatment in septic shock reduces patient survival by nearly 8 percent. Current diagnostic methods depend on bacterial culture, which requires at least a day to detect infections and two to four days to confirm the right antibiotic treatment. Now, a new diagnostic approach for sepsis offers a way to cut this critical time drastically.

Researchers at KTH Royal Institute of Technology (Stockholm, Sweden), in collaboration with Uppsala University (Uppsala, Sweden), have developed a diagnostic method that uses a centrifuge and automated microscopy combined with artificial intelligence (AI). Their system separates bacteria from blood cells using a “smart centrifugation” process and then captures the bacteria in microscale chip channels. The clear liquid layer containing bacteria is analyzed through time-lapse microscopy, with AI software trained to confirm infection in as little as two hours.

The new method was evaluated using blood samples spiked with clinically relevant bacteria. It successfully detected E. coli, K. pneumoniae, and E. faecalis at levels as low as 7–32 colony-forming units per milliliter of blood. However, the findings, published in npj Digital Medicine, showed it was less effective for Staphylococcus aureus, which tends to hide in blood clots, a limitation the researchers are working to overcome.

This advance could allow doctors to start targeted antibiotic treatment much sooner than with traditional culture. Faster diagnosis reduces the need for broad-spectrum antibiotics, which carry risks of toxicity, disruption of gut microbiota, and rising antimicrobial resistance. By confirming bacterial infections within hours rather than days, the method offers safer and more effective treatment pathways.

Future work will focus on adapting the system to detect a wider range of bacteria, improving performance for pathogens such as Staphylococcus aureus, and preparing for clinical validation. The technology’s combination of speed, sensitivity, and automation positions it as a valuable tool for hospitals worldwide in managing sepsis cases.

“It takes a hospital two to four days before they are sure which antibiotic to treat a bloodstream infection with,” said Wouter van der Wijngaart, a professor at KTH Royal Institute of Technology who leads research in microfluidic and biomedical systems. “We’re trying to do this in four to six hours.”

Related Links:
KTH Royal Institute of Technology
Uppsala University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.